cbdMD, Inc. reported earnings results for the second quarter and six months ended March 31, 2022. For the second quarter, the company reported sales was USD 9.95 million compared to USD 12.46 million a year ago. Revenue was USD 9.63 million compared to USD 11.8 million a year ago. Net loss was USD 4.66 million compared to USD 12.51 million a year ago. Basic loss per share from continuing operations was USD 4.5 compared to USD 10.8 a year ago. Diluted loss per share from continuing operations was USD 4.5 compared to USD 10.8 a year ago.
For the six months, sales was USD 19.81 million compared to USD 25.52 million a year ago. Revenue was USD 18.95 million compared to USD 24.13 million a year ago. Net loss was USD 23.82 million compared to USD 21.91 million a year ago. Basic loss per share from continuing operations was USD 19.8 compared to USD 19.35 a year ago. Diluted loss per share from continuing operations was USD 19.8 compared to USD 19.35 a year ago.